Tani Y - Search Results

1

Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study.

Okubo Y, Ohtsuki M, Morita A, Yamaguchi M, Shima T, Tani Y, Nakagawa H; Extension Study Japanese Subgroup. Okubo Y, et al. Among authors: tani y. J Dermatol. 2019 Mar;46(3):186-192. doi: 10.1111/1346-8138.14761. Epub 2019 Jan 23. J Dermatol. 2019. PMID: 30672623 Free PMC article. Clinical Trial.

2

Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch.

Ohtsuki M, Morita A, Igarashi A, Imafuku S, Tada Y, Fujita H, Fujishige A, Yamaguchi M, Teshima R, Tani Y, Nakagawa H. Ohtsuki M, et al. Among authors: tani y. J Dermatol. 2017 Oct;44(10):1105-1111. doi: 10.1111/1346-8138.13911. Epub 2017 May 23. J Dermatol. 2017. PMID: 28543617 Free PMC article. Clinical Trial.

3

Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab.

Morita A, Tani Y, Matsumoto K, Yamaguchi M, Teshima R, Ohtsuki M. Morita A, et al. Among authors: tani y. J Dermatol. 2020 May;47(5):452-457. doi: 10.1111/1346-8138.15278. Epub 2020 Mar 15. J Dermatol. 2020. PMID: 32173900 Free PMC article. Clinical Trial.

4

Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in Japan.

Fujita H, Ohtsuki M, Morita A, Nagao R, Seko N, Matsumoto K, Tani Y, Terui T. Fujita H, et al. Among authors: tani y. J Dermatol. 2021 Feb;48(2):175-183. doi: 10.1111/1346-8138.15655. Epub 2020 Oct 25. J Dermatol. 2021. PMID: 33099791 Free PMC article.

5

Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study.

Itakura A, Tani Y, Kaneko N, Hide M. Itakura A, et al. Among authors: tani y. J Dermatol. 2018 Aug;45(8):963-970. doi: 10.1111/1346-8138.14502. Epub 2018 Jun 13. J Dermatol. 2018. PMID: 29897137 Free PMC article.

6

Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versus-host disease model.

Kuwahara H, Tani Y, Ogawa Y, Takaichi Y, Shiraishi A, Ohtsuki M. Kuwahara H, et al. Among authors: tani y. Clin Immunol. 2001 Jun;99(3):340-6. doi: 10.1006/clim.2001.5028. Clin Immunol. 2001. PMID: 11358429

7

Therapeutic effect of anti-Fas antibody on a collagen induced arthritis model.

Ogawa Y, Kuwahara H, Kimura T, Tani Y, Yonehara S, Shiraishi A, Ohtsuki M. Ogawa Y, et al. Among authors: tani y. J Rheumatol. 2001 May;28(5):950-5. J Rheumatol. 2001. PMID: 11361221

8

A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity.

Ichikawa K, Yoshida-Kato H, Ohtsuki M, Ohsumi J, Yamaguchi J, Takahashi S, Tani Y, Watanabe M, Shiraishi A, Nishioka K, Yonehara S, Serizawa N. Ichikawa K, et al. Among authors: tani y. Int Immunol. 2000 Apr;12(4):555-62. doi: 10.1093/intimm/12.4.555. Int Immunol. 2000. PMID: 10744657

9

Evaluating the cost-effectiveness of secukinumab in moderate-to-severe psoriasis: a Japanese perspective.

Igarashi A, Igarashi A, Graham CN, Gilloteau I, Tani Y. Igarashi A, et al. Among authors: tani y. J Med Econ. 2018 Oct 26:1-9. doi: 10.1080/13696998.2018.1532905. Online ahead of print. J Med Econ. 2018. PMID: 30289010 Free article.

10

Comparative study of intramuscular and intraskeletal osteogenesis by recombinant human bone morphogenetic protein-2.

Okubo Y, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y, Iizuka T. Okubo Y, et al. Among authors: tani y. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jan;87(1):34-8. doi: 10.1016/s1079-2104(99)70291-x. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999. PMID: 9927077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

969 results

Search Page

Filters